Abstract
Background
Low serum level of vitamin D was shown to be associated with cardiovascular diseases as well as the presence of diabetes, dyslipidemia, and hypertension. Vitamin D deficiency is a global problem, and is an Iranian problem as well. To the best of our knowledge, this was the first study on acute myocardial infarction that evaluates the correlation of vitamin D level with inpatients’ outcomes, particularly on the early biomarkers of myocardial remodeling.
Methods
In a prospective study, patients with acute ST segment elevation myocardial infarction were included. The patients’ 25 (OH) D levels were identified and the associations with clinical characteristics, including early remodeling biomarkers and in-hospital outcomes, were investigated.
Results
From the 139 included patients, 80.5% were male. The 25 (OH) deficiency was present in 72.7% of the patients. Hypertension and positive history of cardiovascular drug use were risk factors for the presence of low vitamin D levels (OR = 2.92; CI = 1.34–6.37, P < 0.05) and (OR = 2.36; CI = 1.05–5.29, P < 0.05), respectively. Moreover, a significant positive relationship between the inpatients’ survival and the concentration of vitamin D was present (P < 0.001). By performing a multivariate analysis, we found that there was a significant inverse relationship between the level of 25 (OH) D and the level of MMP-9 after 72 h (P = 0.011).
Conclusion
The results of our study revealed a significant inverse relationship between serum MMP-9 as a biomarker of early remodeling and the level of 25(OH) D in patients after an acute myocardial infarction. Moreover, low level of vitamin D was associated with patients’ mortality in this study.
Similar content being viewed by others
References
Fraser A, Williams D, Lawlor DA (2010) Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001–2006). PLoS One 5(11):e13882
Giovannucci E, Liu Y, Hollis BW, Rimm EB (2008) 5-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168:1174–1180
Dobnig H, Pilz S, Scharnagl H et al (2008) Independent association of low serum 25-hydroxyvitamin d and 1, 25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340–1349
Wang TJ, Pencina MJ, Booth SL et al (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503–511
Mattila C, Knekt P, Männistö S, Rissanen H et al (2007) Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30:2569–2570
Snijder MB, Lips P, Seidell JC et al (2007) Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 261:558–565
Martins D, Wolf M, Pan D et al (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the third national health and nutrition examination survey. Arch Intern Med 167:1159–1165
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281
Hashemipour S, Larijani B, Adibi H et al (2004) Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 4:38
Khosravi A, Taylor R, Naghavi M, Lopez AD (2007) Mortality in the Islamic Republic of Iran, 1964–2004. Bull World Health Organ 85:607–614
Kendrick J, Targher G, Smits G, Chonchol M (2009) 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the third national health and nutrition examination survey. Atherosclerosis 205:255–260
Anderson JL, May HT, Horne BD et al (2010) Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106(7):963–968
Grandi NC, Breitling LP, Vossen CY et al (2010) Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. Am Heart J 159(6):1044–1051
Marniemi J, Alanen E, Impivaara O et al (2005) Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 15:188–197
Sokol SI, Tsang P, Aggarwal V, Melamed ML, Srinivas VS (2011) Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev 19(4):192–201
Klug G, Mayr A, Mair J et al (2011) Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI. Clin Res Cardiol 100:501–510
Melamed ML, Michos ED, Post W, Astor B (2008) 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629–1637
Pittas A, Lau J, Hu F, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029
Yc L (2003) Vitamin D regulation of the renin–angiotensin system. J Cell Biochem 88:327–331
Watson KE, Abrolat ML, Malone LL et al (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755–1760
Carthy E, Yamashita W, Hsu A, Ooi B (1989) 1, 25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 13:954–959
Zittermann A, Jungvogel A, Prokop S et al (2011) Vitamin D deficiency is an independent predictor of anemia in end-stage heart failure. Clin Res Cardiol 100(9):781–788
Scragg R, Sowers M, Bell C (2007) Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20:713–719
Hyppönen E, Boucher BJ, Berry DJ, Power C (2008) 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 57:298–305
Hintzpeter B, Mensink GB, Thierfelder W, Müller MJ, Scheidt-Nave C (2008) Vitamin D status and health correlates among German adults. Eur J Clin Nutr 62:1079–1089
Scragg R, Holdaway I, Jackson R, Lim T (1992) Plasma 25-hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population. Ann Epidemiol 2:697–703
Lind L, Hänni A, Lithell H, Hvarfner A, Sörensen OH, Ljunghall S (1995) Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8:894–901
Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E (2007) Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30:1549–1555
Argiles A (2002) Blood pressure is correlated with vitamin D3 serum levels in dialysis patients. Blood Purif 20:370–375
Muray S, Parisi E, Cardús A, Craver L, Fernández E (2003) Influence of vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D on blood pressure in apparently healthy subjects. J Hypertens 21:2069–2075
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP (2002) 1, 25-Dihydroxyvitamin (D)3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229–238
Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D (2008) Calcium-independent and 1, 25 (OH) D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout nice. Kidney Int 74:170–179
Resnick LM, Muller FB, Laragh JH (1986) Calcium-regulating hormones in essential hypertension: relation to plasma renin activity and sodium metabolism. Ann Intern Med 105:649–654
Guijarro C, Egido J (2001) Transcription factor-kB (NF-kB) and renal disease. Kidney Int 59:415–424
Pilz S, Tomaschitz A, Ritz E, Pieber TR (2006) Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 6:621–630
Wong MS, Delansorne R, Man RY, Vanhoutte PM (2008) Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 295:H289–H296
Talmor Y, Golan E, Benchetrit S et al (2008) Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 294:F1059–F1064
Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R (1990) Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 19:559–563
Wang TJ, Zhang F, Richards JB et al (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376(9736):180–188
Rodriguez G, Starr AZ, Czernuszewicz GZ et al. (2011) Determinants of plasma vitamin D levels in patients with acute coronary syndromes. Eur J Clin Invest. doi:10.1111/j.1365-2362.2011.02540.x
Kilkkinen A, Knekt P, Aro A et al (2009) Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 170:1032–1039
Bahar-Shany K, Ravid A, Koren R (2010) Upregulation of MMP-9 production by TNF alpha in keratinocytes and its attenuation by vitamin D. J Cell Physiol 222:729–737
Anand SP, Selvaraj P (2009) Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis. Clin Immunol 133:126–131
Wasse H, Cardarelli F, De Staercke C, Hooper C, Veledar E, Guessous I (2011) 25-Hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-sectional study of African American ESRD patients. BMC Nephrol 12:24
Pfeffer MA, Braunwald E (1990) Ventricular remodelling after myocardial infarction: experimental observations and clinical implications. Circulation 81:1161–1172
Sutton StJohn, Sharpe N (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101:2981–2988
Kelly D, Cockerill G, Ng LL et al (2007) Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J 28(6):711–718
Bril A, Percevault-Albadini J, Landais J, Toseland C, Gout B (1994) Ventricular remodelling and tolerance to ischaemia in rabbits with myocardial infarction. J Mol Cell Cardiol 26:322–330
Sundström J, Evans JC, Benjamin EJ et al (2004) Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study. Circulation 109(23):2850–2856
Hsia J, Heiss G, Ren H et al (2007) Calcium/vitamin D supplementation and cardiovascular events. Circulation 115:846–854
LaCroix AZ, Kotchen J, Anderson G et al (2009) Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women’s Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci 64:559–567
Wang L, Manson JE, Song Y, Sesso HD (2010) Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 152:315–323
Autier P, Gandini S (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167:1730–1737
Acknowledgments
This study was supported by a grant from Office of Vice-Chancellor for Research of Tehran University of Medical Sciences.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khalili, H., Talasaz, A.H. & Salarifar, M. Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clin Res Cardiol 101, 321–327 (2012). https://doi.org/10.1007/s00392-011-0394-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-011-0394-0